|
Journal of Lipid Research, Vol. 42, 1298-1307, August 2001
Copyright © 2001 by Lipid Research, Inc.
High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey
Carlos A. Aguilar-Salinasa,
Gustavo Olaizb,
Victoria Vallesa,
Juan Manuel Ríos Torresa,
Francisco J. Gómez Péreza,
Juan A. Rulla,
Rosalba Rojasb,
Aurora Francob, and
Jaime Sepulvedab
a Departamento de Endocrinología y Metabolismo de Lípidos, del Instituto Nacional de Ciencias Médicas y Nutrición, Vasco de Quiroga 15, Mexico City 14000, Mexico
b Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico
Correspondence to:
Carlos A. Aguilar-Salinas, To whom correspondence should be addressed., caguilarsalinas{at}yahoo.com (E-mail)
The prevalence of lipid abnormalities revealed in a survey done in 417 Mexican cities is described. Information was obtained on 15,607 subjects, aged 20 to 69 years. In this report, only samples obtained after a 9- to 12-h fast were included (2,256 cases: 953 men and 1,303 women). The population is representative of Mexican urban adults. Mean lipid concentrations were: cholesterol, 4.80 mmol/l; triglycerides, 2.39 mmol/l; HDL cholesterol, 1.00 mmol/l; and LDL cholesterol, 3.06 mmol/l. The most prevalent abnormality was HDL cholesterol below 0.9 mmol/l (46.2% for men and 28.7% for women). Hypertriglyceridemia (>2.26 mmol/l) was the second most prevalent abnormality (24.3%). Severe hypertriglyceridemia (>11.2 mmol/l) was observed in 0.42% of the population. Increased LDL cholesterol ( 4.21 mmol/l) was observed in 11.2% of the sample. Half of the hypertriglyceridemic subjects had a mixed dyslipidemia or low HDL cholesterol. More than 50% of the low HDL cholesterol cases were not related to hypertriglyceridemia. Insulin resistance was found in 59% of them.
In conclusion, the prevalence of hypoalphalipoproteinemia and other forms of dyslipidemia in Mexican adults is very high and it is among the highest previously reported worldwide. Aguilar-Salinas, C. A., G. Olaiz, V. Valles, J. M. Ríos Torres, F. J. Gómez Pérez, J. A. Rull, R. Rojas, A. Franco, and J. Sepulveda. High prevalence of low HDL cholesterol concentrations and mixed hyperlipidemia in a Mexican nationwide survey. J. Lipid Res. 2001. 42: 1298;1307.
Supplementary key words:
diabetes, obesity, hypertension, cholesterol, Mexico, insulin resistance, hypertriglyceridemia

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Meaney, G. Ceballos, J. Asbun, G. Solache, E. Mendoza, A. Vela, and E. Meaney
The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study
J. Clin. Pharmacol.,
July 1, 2009;
49(7):
838 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Martinez-Lopez, B. Ruiz-Madrigal, I. Hernandez-Canaveral, and A. Panduro
Association of the T54 allele of the FABP2 gene with cardiovascular risk factors in obese Mexican subjects
Diabetes and Vascular Disease Research,
September 1, 2007;
4(3):
235 - 236.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Villarreal-Molina, C. A. Aguilar-Salinas, M. Rodriguez-Cruz, D. Riano, M. Villalobos-Comparan, R. Coral-Vazquez, M. Menjivar, P. Yescas-Gomez, M. Konigsoerg-Fainstein, S. Romero-Hidalgo, et al.
The ATP-Binding Cassette Transporter A1 R230C Variant Affects HDL Cholesterol Levels and BMI in the Mexican Population: Association With Obesity and Obesity-Related Comorbidities
Diabetes,
July 1, 2007;
56(7):
1881 - 1887.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Aguilar-Salinas, R. Rojas, C. Gonzalez-Villalpando, F. J. Gomez-Perez, R. Mehta, G. Olaiz, J. A. Rull, and D. R. Cox
Design and validation of a population-based definition of the metabolic syndrome.
Diabetes Care,
November 1, 2006;
29(11):
2420 - 2426.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bruckert
Epidemiology of low HDL-cholesterol: results of studies and surveys
Eur. Heart J. Suppl.,
October 1, 2006;
8(suppl_F):
F17 - F22.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Espinosa-Larranaga, M. Vejar-Jalaf, and R. Medina-Santillan
The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor
Diabetes and Vascular Disease Research,
October 1, 2005;
2(1_suppl):
S1 - S8.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Huertas-Vazquez, C. Aguilar-Salinas, A. J. Lusis, R. M. Cantor, S. Canizales-Quinteros, J. C. Lee, L. Mariana-Nunez, R.-M. L. Riba-Ramirez, A. Jokiaho, T. Tusie-Luna, et al.
Familial Combined Hyperlipidemia in Mexicans: Association With Upstream Transcription Factor 1 and Linkage on Chromosome 16q24.1
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2005;
25(9):
1985 - 1991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bruckert, R. Pamphile, F. McCoy, and P. Andre
Defining the prevalence of low HDL-C in a European cohort of dyslipidaemic patients
Eur. Heart J. Suppl.,
July 1, 2005;
7(suppl_F):
F23 - F26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Jimenez-Cruz and M. Bacardi-Gascon
The Fattening Burden of Type 2 Diabetes on Mexicans: Projections from early growth to adulthood
Diabetes Care,
May 1, 2004;
27(5):
1213 - 1215.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Aguilar-Salinas, O. V. Monroy, F. J. Gomez-Perez, A. G. Chavez, A. L. Esqueda, V. M. Cuevas, J. A. Rull-Rodrigo, and R. T. Conyer
Characteristics of Patients With Type 2 Diabetes in Mexico: Results from a large population-based nationwide survey
Diabetes Care,
July 1, 2003;
26(7):
2021 - 2026.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Canizales-Quinteros, C. A. Aguilar-Salinas, E. Reyes-Rodriguez, L. Riba, M. Rodriguez-Torres, S. Ramirez-Jimenez, A. Huertas-Vazquez, V. Fragoso-Ontiveros, A. Zentella-Dehesa, J. L. Ventura-Gallegos, et al.
Locus on Chromosome 6p Linked to Elevated HDL Cholesterol Serum Levels and to Protection Against Premature Atherosclerosis in a Kindred With Familial Hypercholesterolemia
Circ. Res.,
March 21, 2003;
92(5):
569 - 576.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|